- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01398787
Evaluation of the Cosmetic Performance of AIR OPTIX® COLORS
February 18, 2014 updated by: CIBA VISION
Cosmetic Validation (US): AIR OPTIX® COLORS Among Habitual Wearers of FRESHLOOK®
The purpose of this study was to evaluate the cosmetic performance of AIR OPTIX® COLORS contact lenses compared to FRESHLOOK® COLORBLENDS contact lenses in habitual FRESHLOOK® COLORBLENDS contact lens wearers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this non-dispensing trial, each participant wore 4 pairs of color contact lenses (gray, blue, green, hazel) sequentially for less than 10 minutes each in a contralateral fashion (test lens in one eye, control lens in the other eye).
Randomization took place for each of the 4 pairs of lenses as to which eye (left or right) wore the test and which wore the control.
Participants were selected based on eye color (dark vs light/medium).
The primary analysis population (AP1) was pre-specified as participants of any eye color who habitually wore FRESHLOOK® COLORBLENDS lenses in one of the four colors tested in this trial.
Pair 1 lenses were dispensed per the participant's habitual lens color.
Study Type
Interventional
Enrollment (Actual)
198
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Sign written Informed Consent document. If under legal age of consent, legally authorized representative must sign Informed Consent document and subject must sign Assent document.
- Have spectacles that provide acceptable near vision to wear over study lenses as needed to evaluate cosmetics of the lenses.
- Habitually wear FRESHLOOK® COLORBLENDS lenses at least two days per week.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Eye injury or surgery within twelve weeks of enrollment in this trial.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in any clinical trial.
- Evidence of systematic or ocular abnormality, infection, or disease which is likely to affect successful wear of contact lenses or use of accessory solutions as determined by the investigator.
- Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AIR OPTIX® COLORS
Lotrafilcon B contact lens with color randomly assigned to one eye, with phemfilcon A contact lens with color in the fellow eye for contralateral wear
|
Plano (-0.00 diopter) silicone hydrogel contact lens in 1 of 4 colors: gray, blue, green, pure hazel
Other Names:
|
|
Active Comparator: FRESHLOOK® COLORBLENDS
Phemfilcon A contact lens with color randomly assigned to one eye, with lotrafilcon B contact lens with color in the fellow eye for contralateral wear
|
Plano (-0.00 diopter) hydrogel contact lens in 1 of 4 colors: ColorBlends gray, Colorblends blue, Colorblends green, Colorblends pure hazel
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Preference
Time Frame: Day 1, 2-10 minutes after lens insertion
|
The participant compared Pair 1 study lenses on eye and indicated overall preference using a 4-point Likert scale (prefer lens in the left eye, prefer lens in the right eye, no preference, or both eyes are equal).
Overall preference is reported as the percentage of participants who preferred the study lens.
Each lens was assessed separately.
This outcome measure was pre-specified for Analysis Population 1 (AP1).
|
Day 1, 2-10 minutes after lens insertion
|
|
Initial Comfort Preference
Time Frame: Day 1, 2 minutes after lens insertion
|
The participant compared the initial comfort (way it feels) of Pair 1 study lenses and indicated preference using a 4-point Likert scale (prefer lens in the left eye, prefer lens in the right eye, no preference, or both eyes are equal).
Initial comfort preference is reported as the percentage of participants who preferred the study lens.
Each lens was assessed separately.
This outcome measure was pre-specified for Analysis Population 1 (AP1).
|
Day 1, 2 minutes after lens insertion
|
|
Appearance Preference
Time Frame: Day 1, 2-10 minutes after lens insertion
|
The participant compared the appearance (way it looks) of Pair 1 study lenses on eye and indicated preference using a 4-point Likert scale (prefer lens in the left eye, prefer lens in the right eye, no preference, or both eyes are equal).
Appearance preference is reported as the percentage of participants who preferred the study lens.
Each lens was assessed separately.
This outcome measure was pre-specified for Analysis Population 1 (AP1).
|
Day 1, 2-10 minutes after lens insertion
|
|
Subjective Rating of Initial Comfort
Time Frame: Day 1, 2 minutes after lens insertion
|
The participant compared the initial comfort (way it feels) of Pair 1 study lenses and rated initial comfort using a 10-point scale (1=poor, 10=excellent).
Each lens was assessed separately.
This outcome measure was pre-specified for Analysis Population 1 (AP1).
|
Day 1, 2 minutes after lens insertion
|
|
Percent Positive Responses: Cosmetic Appearance (Strongly Agree, Agree)
Time Frame: Day 1, 2-10 minutes after lens insertion
|
The participant compared the cosmetic appearance of Pair 1 study lenses on eye and answered 9 appearance-related questions using a 4-point Likert scale (strongly agree, agree, disagree, strongly disagree).
The combined percentage of the top two responses (strongly agree, agree) is reported for each question.
Each lens was assessed separately.
This outcome measure was pre-specified for Analysis Population 1 (AP1).
|
Day 1, 2-10 minutes after lens insertion
|
|
Percent Positive Purchase Intent (Definitely Would Buy, Probably Would Buy)
Time Frame: Day 1, 2-10 minutes after lens insertion
|
The participant compared Pair 1 study lenses and indicated purchase intent by answering the following question, "Assuming these lenses were at a price you would expect to pay, how likely would you be to purchase these lenses?" using a 5-point Likert scale (definitely would buy, probably would buy, might or might not buy, probably would not buy, definitely would not buy).
The combined percentage of the top two responses (definitely would buy, probably would buy) is reported.
Each lens was assessed separately.
This outcome measure was pre-specified for Analysis Population 1 (AP1).
|
Day 1, 2-10 minutes after lens insertion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sharon Holden Thomas, O.D., Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
July 19, 2011
First Submitted That Met QC Criteria
July 19, 2011
First Posted (Estimate)
July 21, 2011
Study Record Updates
Last Update Posted (Estimate)
March 28, 2014
Last Update Submitted That Met QC Criteria
February 18, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- P-383-C-004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cosmetic Appearance
-
Alcon ResearchWithdrawn
-
Alcon ResearchWithdrawn
-
CIBA VISIONCompletedCosmetic AppearanceSingapore
-
University of California, DavisCompletedStriae Distensae | Stretch Marks | Cosmetic Appearance of Stretch MarksUnited States
-
Ricardo A Gutierrez Ramirez, MD, MSc, FACOGCompletedCesarean Section Scar | Tissue Adhesives | Cesarean Wound Repair | Cosmetic Appearance of Cesarean ScarHonduras
-
University of South FloridaCompletedSurgical Site Infection | Post Operative Pain | Cosmetic Appearance of Cesarean ScarUnited States
-
Christie Medical Holdings, Inc.Completed
-
Vitro Biopharma Inc.CompletedCosmetic EffectUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Seoul National University HospitalUnknown
Clinical Trials on Lotrafilcon B contact lens with color
-
CIBA VISIONCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive Error | Myopia
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
CIBA VISIONCompleted